CN100361705C - A traditional Chinese medicine composition for treating chronic atrophic gastritis - Google Patents
A traditional Chinese medicine composition for treating chronic atrophic gastritis Download PDFInfo
- Publication number
- CN100361705C CN100361705C CNB200510107415XA CN200510107415A CN100361705C CN 100361705 C CN100361705 C CN 100361705C CN B200510107415X A CNB200510107415X A CN B200510107415XA CN 200510107415 A CN200510107415 A CN 200510107415A CN 100361705 C CN100361705 C CN 100361705C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- traditional chinese
- atrophic gastritis
- chronic atrophic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 208000016644 chronic atrophic gastritis Diseases 0.000 title claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 239000004863 Frankincense Substances 0.000 claims abstract description 16
- 229940079593 drug Drugs 0.000 claims description 23
- 241000208340 Araliaceae Species 0.000 claims description 17
- 241000721047 Danaus plexippus Species 0.000 claims description 14
- 239000002671 adjuvant Substances 0.000 claims description 8
- 241000717739 Boswellia sacra Species 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 2
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 18
- 235000008397 ginger Nutrition 0.000 abstract description 18
- 241001522129 Pinellia Species 0.000 abstract description 16
- 235000003717 Boswellia sacra Nutrition 0.000 abstract description 13
- 240000007551 Boswellia serrata Species 0.000 abstract description 13
- 235000012035 Boswellia serrata Nutrition 0.000 abstract description 13
- 240000004534 Scutellaria baicalensis Species 0.000 abstract description 11
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 9
- 229940010454 licorice Drugs 0.000 abstract description 9
- 241000037740 Coptis chinensis Species 0.000 abstract description 6
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 241000234314 Zingiber Species 0.000 description 17
- 239000000843 powder Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 241000202807 Glycyrrhiza Species 0.000 description 12
- 241001673966 Magnolia officinalis Species 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- 239000001116 FEMA 4028 Substances 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000001256 steam distillation Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000010329 Xiangshaliujunzi decoction Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗慢性萎缩性胃炎的中药组合物。该中药组合物的成分及重量百分比为:法半夏3.5%-4%,黄连18%-19%,干姜18%-19%,人参9%-9.5%,黄芩18%-19%,厚朴9%-9.5%,乳香3.5%-4%,炙甘草18%-19%。该药可用于治疗慢性萎缩性胃炎寒热错杂症。本发明涉及的中药组合物临床治愈率占10%;显效率占33%;有效率占43%;总有效率87%。The invention relates to a traditional Chinese medicine composition for treating chronic atrophic gastritis. The composition and weight percentage of the traditional Chinese medicine composition are: 3.5%-4% of Pinellia chinensis, 18%-19% of Coptis chinensis, 18%-19% of dried ginger, 9%-9.5% of ginseng, 18%-19% of Scutellaria baicalensis, thick Park 9%-9.5%, frankincense 3.5%-4%, roasted licorice 18%-19%. The medicine can be used for the treatment of chronic atrophic gastritis with mixed cold and heat. The clinical cure rate of the traditional Chinese medicine composition involved in the present invention accounts for 10%; the effective rate accounts for 33%; the effective rate accounts for 43%; and the total effective rate accounts for 87%.
Description
技术领域technical field
本发明属于中药领域,涉及一种治疗慢性萎缩性胃炎的中药组合物。The invention belongs to the field of traditional Chinese medicines and relates to a traditional Chinese medicine composition for treating chronic atrophic gastritis.
背景技术Background technique
慢性萎缩性胃炎是以胃粘膜腺体萎缩为特征的一种常见消化道疾病,WHO将其列为胃癌的癌前状态,目前还没有根治慢性萎缩性胃炎的特效药。常用中药方剂如四逆散(出自《伤寒论》,载于《方剂学》58页)、三仁汤(出自《温病条辨》,载于《方剂学讲义》190页)、香砂六君子汤(出自《时方歌括》,载于《温病学》231页)、沙参麦冬汤(出自《温病条辨》,载于《方剂学》231页)等施治原理不同,但都不能全面的治疗慢性萎缩性胃炎。Chronic atrophic gastritis is a common digestive tract disease characterized by atrophy of gastric mucosal glands. WHO lists it as a precancerous state of gastric cancer. Currently, there is no specific drug for chronic atrophic gastritis. Commonly used traditional Chinese medicine prescriptions such as Sini Powder (from "Treatise on Febrile Diseases", contained in "Prescription Science" page 58), Sanren Decoction (from "Warm Disease Tiaobian", contained in "Prescription Science Lecture Notes" page 190), Xiangsha Liu Junzi Decoction (from "Shi Fang Ge Kuo", contained in "Fresh Diseases", page 231), Shashen Maidong Decoction (from "Febrile Diseases", contained in "Prescriptions", page 231) and other treatment principles are different , but none of them can comprehensively treat chronic atrophic gastritis.
发明内容Contents of the invention
本发明的目的是提供一种治疗慢性萎缩性胃炎的中药组合物。本发明能有效遏制胃粘膜萎缩,阻碍其向癌发展,具有很好的疗效。The object of the invention is to provide a traditional Chinese medicine composition for treating chronic atrophic gastritis. The invention can effectively restrain the atrophy of the gastric mucosa, hinder its development to cancer, and has good curative effect.
本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且中药组合物的组成成分及重量百分比为:法半夏3.5%-4%,黄连18%-19%,干姜18%-19%,人参9%-9.5%,黄芩18%-19%,厚朴9%-9.5%,乳香3.5%-4%,炙甘草18%-19%。A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is formulated according to monarch, minister, and envoy: Pinellia is the monarch drug; Coptidis Rhizome, dried ginger, and ginseng are minister drugs; Scutellaria baicalensis, Magnolia officinalis, and frankincense are adjuvant drugs Radix Glycyrrhiza is used as medicine; and the composition and weight percentage of the traditional Chinese medicine composition are: Pinellia chinensis 3.5%-4%, Coptidis 18%-19%, dried ginger 18%-19%, ginseng 9%-9.5%, Scutellaria baicalensis 18%-19%, Magnolia officinalis 9%-9.5%, frankincense 3.5%-4%, roasted licorice 18%-19%.
本发明的一种治疗慢性萎缩性胃炎的中药组合物系根据中医药学理论,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is based on the theory of traditional Chinese medicine, according to the prescription of monarch, minister, adjuvant and envoy: Pinellia is the monarch drug; Coptis chinensis, dried ginger and ginseng are minister drugs; Pu and frankincense are adjuvant medicines; roasted licorice is an envoy;
下面,根据中医药学理论,对本发明的一种治疗慢性萎缩性胃炎的中药组合物的配伍组分进一步予以说明:Below, according to the theory of traditional Chinese medicine, the compatible components of a kind of Chinese medicine composition for treating chronic atrophic gastritis of the present invention are further described:
半夏为君药。发挥其健脾和胃,散结消痞,降逆除胀止痛作用,主治脾胃虚弱,寒热错杂脾证;黄连,协助君药祛湿调中,发挥其清热燥湿,调胃厚肠,坚阴止痢作用;干姜,协助君药,发挥其温补脾胃,散寒降逆止痛作用;人参,协助君药,发挥其补中缓急作用;黄芩,协助黄连清热,发挥其清热燥湿,坚阴止利作用;厚朴,协助半夏、干姜温中降逆,发挥其行气燥湿,除胀消积作用;乳香,协助半夏、干姜辛散,发挥其行气止痛化瘀作用;炙甘草,一方面,佐助人参补中虚,另一方面,调和诸药,使药性调和,利于养胃。Pinellia is the king medicine. Give play to its invigorating the spleen and harmonizing the stomach, dissipating stagnation and eliminating swelling, lowering the adverse effect of removing swelling and relieving pain, and mainly treating weakness of the spleen and stomach, cold and heat mixed spleen syndrome; Coptis chinensis, assisting the monarch drug in dispelling dampness and regulating the middle, exerting its heat-clearing and damp-drying, regulating the stomach and thickening the intestines, strengthening the Yin and stop dysentery; Dried ginger, assisting the monarch drug, exerts its effect of warming and tonifying the spleen and stomach, dispelling cold and reducing adverse reactions; Magnolia officinalis, assists pinellia and dried ginger to warm the middle and reduce adverse events, exerts its function of promoting qi, drying dampness, eliminating swelling and eliminating accumulation; frankincense, assists pinellia and dried ginger, exerts its function of promoting qi, relieving pain and removing blood stasis; Roasted licorice, on the one hand, assists ginseng to invigorate the deficiency in the middle, on the other hand, reconciles various medicines to harmonize the properties of the medicine, which is beneficial to nourishing the stomach.
本发明的制备方法是,将配比量的2/5的人参与全部配比量的乳香粉碎成细粉,备用。配比量的黄连加水煎煮,滤过,合并滤液,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,80℃干燥,粉碎成细粉;配比量的干姜加水浸泡,水蒸汽蒸馏提取挥发油,药渣及蒸馏后水液备用。挥发油用β-环糊精包合,抽滤,沉淀物烘干备用;将上述药渣与配比量的黄芩、厚朴,炙甘草、法半夏及配比量的3/5的人参加水煎煮,滤过,滤液与干姜蒸馏后水液合并,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,加入上述细粉,搅拌均匀,80℃干燥,粉碎成细粉,与黄连浸膏粉及包合物混合均匀即得本发明的中药组合物;本发明还可以继续用中药公知的技术方法制成任何固体剂型,包括胶囊剂、片剂、散剂或丸剂。The preparation method of the present invention comprises: pulverizing 2/5 of the proportioning amount of ginseng into a fine powder and putting it aside for later use. Coptidis Rhizoma Coptidis in proportion is decocted with water, filtered, combined filtrates, concentrated under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), alcohol precipitation (to make the ethanol concentration reach 65%-75%), stirred evenly, and statically Set aside for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), dry at 80°C, and pulverize into fine powder; soak the proportioned amount of dried ginger in water, steam distillation to extract volatile oil , dregs and distilled water for later use. The volatile oil is clathrated with β-cyclodextrin, suction filtered, and the sediment is dried for later use; the above-mentioned medicinal residues are mixed with the proportioned amount of Scutellaria baicalensis, Magnolia officinalis officinalis, Zhigancao, Fa Pinellia, and 3/5 of the proportioned amount. Decoct with water, filter, combine the filtrate with the dried ginger after distillation, concentrate under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), precipitate with alcohol (to make the ethanol concentration reach 65%-75%), and stir evenly , stand still for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), add the above fine powder, stir evenly, dry at 80°C, crush into fine powder, and mix with Coptis chinensis extract Mix the powder and the clathrate evenly to obtain the traditional Chinese medicine composition of the present invention; the present invention can also continue to use the known techniques of traditional Chinese medicine to make any solid dosage form, including capsules, tablets, powders or pills.
使用本发明的治疗慢性萎缩性胃炎的中药组合物治疗慢性萎缩性胃炎60例,治疗效果如下:Use the Chinese medicine composition for the treatment of chronic atrophic gastritis of the present invention to treat 60 cases of chronic atrophic gastritis, and the therapeutic effect is as follows:
参照卫生部《中药新药治疗慢性萎缩性胃炎临床指导原则》、《现代中医内科诊断治疗学》、《实用中医内科学》、全国高等专科医药院校教材《内科学》等诊断标准治疗慢性萎缩性胃炎60例,中医辩证属寒热错杂证,临床症状以胃部饱胀满闷、胀痛、食欲不振、嗳气、嘈杂泛酸、大便溏薄或干结、乏力、消瘦、食辛辣、凉、腻食物胃胀痛不适加重为主,舌象以舌淡或红、苔薄白、黄或腻为主,脉象以脉沉弦、细、缓为主。60例患者中,临床治愈6例,占10%;显效20例,占33%;有效26例,占43%;无效8例,占13%,总有效率87%。Treat chronic atrophic gastritis with reference to the Ministry of Health's "Clinical Guidelines for the Treatment of Chronic Atrophic Gastritis with New Drugs of Traditional Chinese Medicine", "Diagnosis and Therapeutics of Modern Traditional Chinese Medicine", "Practical Internal Medicine of Traditional Chinese Medicine", and the textbook "Internal Science" of national medical colleges and universities. 60 cases of gastritis, TCM dialectics belong to mixed syndrome of cold and heat, clinical symptoms include stomach fullness, fullness, pain, loss of appetite, belching, noisy pantothenic acid, loose or dry stool, fatigue, weight loss, eating spicy, cold, greasy food stomach Distending pain and discomfort are mainly aggravated. The tongue is mainly pale or red, with thin white, yellow or greasy fur. The pulse is mainly deep and stringy, thin and slow. Among the 60 patients, 6 cases were clinically cured, accounting for 10%; 20 cases were markedly effective, accounting for 33%; 26 cases were effective, accounting for 43%; 8 cases were ineffective, accounting for 13%, and the total effective rate was 87%.
具体实施方式Detailed ways
实施例1:本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且该中药组合物的组成成分及其重量百分比为:法半夏3.7%,黄连18.5%,干姜18.5%,人参9.3%,黄芩18.5%,厚朴9.3%,乳香3.7%,炙甘草18.5%。Embodiment 1: A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis of the present invention, carries out prescription according to monarch, minister, adjuvant, envoy: Fa Pinellia is monarch medicine; , frankincense is an adjuvant drug; Radix Glycyrrhiza is an envoy; and the composition and weight percentages of the Chinese medicine composition are: Pinellia chinensis 3.7%, Coptidis 18.5%, dried ginger 18.5%, ginseng 9.3%, scutellaria baicalensis 18.5%, thick Pu 9.3%, frankincense 3.7%, roasted licorice 18.5%.
实施例2:Example 2:
本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且该中药胶囊组成成分及其重量百分比为:法半夏3.5%,黄连19%,干姜18%,人参9.5%,黄芩18%,厚朴9.5%,乳香4%,炙甘草18%。A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is formulated according to monarch, minister, adjuvant and envoy: Fa Pinellia is the monarch drug; Coptidis Rhizoma, Dried Ginger, and Ginseng are minister drugs; Scutellaria baicalensis, Magnolia officinalis, and frankincense are assistants. Radix Glycyrrhiza is used as medicine; and the composition and weight percentage of the Chinese medicine capsule are: Pinellia chinensis 3.5%, Coptidis 19%, dried ginger 18%, ginseng 9.5%, Scutellaria baicalensis 18%, Magnolia officinalis 9.5%, frankincense 4% %, Zhi Licorice 18%.
实施例3:Example 3:
本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且该中药胶囊组成成分及其重量百分比为:法半夏4%,黄连18%,干姜19%,人参9%,黄芩19%,厚朴9%,乳香3.5%,炙甘草19%。A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is formulated according to monarch, minister, adjuvant and envoy: Fa Pinellia is the monarch drug; Coptidis Rhizoma, Dried Ginger, and Ginseng are minister drugs; Scutellaria baicalensis, Magnolia officinalis, and frankincense are assistants. Radix Glycyrrhiza is used as medicine; and the composition and weight percentage of the Chinese medicine capsule are: Pinellia 4%, Coptidis 18%, Dried Ginger 19%, Ginseng 9%, Scutellaria baicalensis 19%, Magnolia officinalis 9%, Frankincense 3.5% %, Zhi Licorice 19%.
制备方法实施例1:Preparation method embodiment 1:
取人参100g(3.7%)与乳香100g(3.7%)粉碎成细粉,备用。黄连500g(18.5%)加水煎煮,滤过,合并滤液,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,80℃干燥,粉碎成细粉。干姜500g(18.5%)加水浸泡,水蒸汽蒸馏提取挥发油,药渣及蒸馏后水液备用。挥发油用β-环糊精包合,抽滤,沉淀物烘干备用。将上述药渣与黄芩500g(18.5%)、人参150g(5.6%)、厚朴250g(9.3%),炙甘草500g(18.5%)、法半夏100g(3.7%)加水煎煮,滤过,滤液与干姜蒸馏后水液合并,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,加入上述细粉,搅拌均匀,80℃干燥,粉碎成细粉,与黄连浸膏粉及包合物混合均匀即得本发明的中药组合物。Get ginseng 100g (3.7%) and frankincense 100g (3.7%) and grind into fine powder, set aside. Add 500 g (18.5%) of Coptidis Rhizome to decoct with water, filter, combine the filtrates, concentrate under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), precipitate with alcohol (to make the ethanol concentration reach 65%-75%), stir evenly, Stand still for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), dry at 80°C, and pulverize into fine powder. Dried ginger 500g (18.5%) is soaked in water, steam distillation extracts volatile oil, medicinal residues and distilled water for later use. The volatile oil was clathrated with β-cyclodextrin, filtered with suction, and the precipitate was dried for later use. Decoct the above medicinal residues with 500g (18.5%) of Scutellaria baicalensis, 150g (5.6%) of ginseng, 250g (9.3%) of Magnolia bark, 500g (18.5%) of roasted licorice, and 100g (3.7%) of Pinellia chinensis, and filter. The filtrate and dried ginger are distilled and the water liquid is combined, concentrated under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), alcohol precipitation (making the ethanol concentration reach 65%-75%), stirring evenly, standing for 24 hours, and filtering After that, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), add the above-mentioned fine powder, stir evenly, dry at 80°C, crush into fine powder, and mix evenly with Coptis chinensis extract powder and clathrate That is, the Chinese medicine composition of the present invention is obtained.
制备方法施例2:Preparation method embodiment 2:
取人参115g(4%)与乳香115g(4%)粉碎成细粉,备用。黄连545g(19%)加水煎煮,滤过,合并滤液,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,80℃干燥,粉碎成细粉。干姜515g(18%)加水浸泡,水蒸汽蒸馏提取挥发油,药渣及蒸馏后水液备用。挥发油用β-环糊精包合,抽滤,沉淀物烘干备用。将上述药渣与黄芩515g(18%)、人参155g(5%)、厚朴270(9.5%),炙甘草515g(18%)、法半夏100g(3.5%)加水煎煮,滤过,滤液与干姜蒸馏后水液合并,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,加入上述细粉,搅拌均匀,80℃干燥,粉碎成细粉,与黄连浸膏粉及包合物混合均匀即得本发明的中药组合物。Get ginseng 115g (4%) and frankincense 115g (4%) and grind into fine powder, set aside. Add 545g (19%) of Coptidis Rhizome to decoct with water, filter, combine the filtrates, concentrate under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), precipitate with alcohol (to make the ethanol concentration reach 65%-75%), stir evenly, Stand still for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), dry at 80°C, and pulverize into fine powder. Dried ginger 515g (18%) is soaked in water, steam distillation extracts volatile oil, medicinal dregs and water liquid after distillation are set aside. The volatile oil was clathrated with β-cyclodextrin, filtered with suction, and the precipitate was dried for later use. Add water to decoct the above-mentioned medicinal residues, 515g (18%) of Scutellaria baicalensis, 155g (5%) of ginseng, 270 bark officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis Magnolia officinalis officinalis Officinalis Magnolia officinalis Bark 270 (9.5%), Zhi licorice 515g (18%), Pinellia chinensis 100g (3.5%) and decoct in water, filter, The filtrate and dried ginger are distilled and the water liquid is combined, concentrated under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), alcohol precipitation (making the ethanol concentration reach 65%-75%), stirring evenly, standing for 24 hours, and filtering After that, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), add the above-mentioned fine powder, stir evenly, dry at 80°C, crush into fine powder, and mix evenly with Coptis chinensis extract powder and clathrate That is, the Chinese medicine composition of the present invention is obtained.
本发明的治疗实施例1 袁某,男,33岁,长春市人。患胃胀,胃痛,消瘦1年。每与饮食不当而胃痛,彻夜不眠。平素胃饱胀,无食欲,大便干稀不调,易感冒,身体消瘦明显。于市内多家医院诊为慢性萎缩性胃炎。查:舌苔红,苔白腻,脉沉缓。中医诊断为痞证,辨证属寒热错杂,用复方夏连胶囊汤剂治疗1个月,症状明显减轻。原方小量服用近3个月,症状全无,体重增加。5年后随访,未再复发。Treatment example 1 of the present invention Yuan, male, 33 years old, from Changchun City. Suffering from bloating, stomach pain, weight loss for 1 year. Stomach pain every time with improper diet, sleepless all night. I usually have a full stomach, no appetite, dry and loose stools, easy to catch colds, and obvious body weight loss. Examined as chronic atrophic gastritis in many hospitals in the city. Look into: red tongue fur, white and greasy fur, deep and slow pulse. Diagnosed by traditional Chinese medicine as lump syndrome, syndrome differentiation is mixed cold and heat, treated with compound Xialian capsule decoction for 1 month, the symptoms were obviously relieved. The original prescription has been taken in a small amount for nearly 3 months, no symptoms at all, and weight gain. Follow up a case by regular visits to after 5 years, do not relapse again.
本发明的治疗实施例2 郝某,男,45岁,长春市人。疼痛,胃中胀满,嘈杂10余年,加重1年。因其是出租车司机,饮食无规律,饥饱不调引起发病。由市内多家医院诊为慢性萎缩性胃炎,服用中西药物无效。平素食欲不振,胃中饱胀,嘈杂,胃痛,常在行车时用手顶住胃部以缓解疼痛。大便干稀不调,极易疲劳,睡眠后疲劳不能解除,身体极度消瘦,用手揉摸胃部觉舒。查舌淡、苔薄黄干,脉细。中医辩证为胃脘痛,证属寒热错杂,治用复方夏连胶囊汤剂。2周后,症状明显改善,3个月后,症状消失,5年后随访,未再复发,身体健壮。Treatment Example 2 of the present invention Hao, male, 45 years old, from Changchun City. Pain, fullness in the stomach, noisy for more than 10 years, aggravated for 1 year. Because he is a taxi driver, his diet is irregular, and his hunger and fullness are not adjusted to cause the disease. It was diagnosed as chronic atrophic gastritis by many hospitals in the city, and taking Chinese and Western medicines was ineffective. Ordinary loss of appetite, full stomach, noisy, stomach pain, often with hands against the stomach to relieve pain while driving. Dry and loose stools, easy fatigue, fatigue can not be relieved after sleep, the body is extremely thin, and the stomach feels comfortable when rubbed with hands. Look into pale tongue, thin yellow fur, thready pulse. The TCM syndrome is epigastric pain, and the syndrome is cold and heat mixed. Compound Xialian Capsule Decoction is used for treatment. After 2 weeks, the symptoms were obviously improved, and after 3 months, the symptoms disappeared. After 5 years of follow-up, there was no recurrence and the body was healthy.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510107415XA CN100361705C (en) | 2005-09-30 | 2005-09-30 | A traditional Chinese medicine composition for treating chronic atrophic gastritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510107415XA CN100361705C (en) | 2005-09-30 | 2005-09-30 | A traditional Chinese medicine composition for treating chronic atrophic gastritis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1745844A CN1745844A (en) | 2006-03-15 |
CN100361705C true CN100361705C (en) | 2008-01-16 |
Family
ID=36165662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510107415XA Expired - Fee Related CN100361705C (en) | 2005-09-30 | 2005-09-30 | A traditional Chinese medicine composition for treating chronic atrophic gastritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100361705C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9193756B2 (en) | 2008-02-19 | 2015-11-24 | National University Corporation Asahikawa Medical College | Adrenomedullin production enhancer |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108619480A (en) * | 2018-08-10 | 2018-10-09 | 重庆市渝北区中医院 | A kind of Chinese medicine composition that treating atrophic gastritis and its application |
CN116942785B (en) * | 2023-08-29 | 2024-09-10 | 北京中医药大学 | Traditional Chinese medicine preparation for treating chronic atrophic gastritis and precancerous lesions of gastric cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1531961A (en) * | 2003-03-18 | 2004-09-29 | 李政育 | Traditional Chinese medicine for treating paraplegia |
-
2005
- 2005-09-30 CN CNB200510107415XA patent/CN100361705C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1531961A (en) * | 2003-03-18 | 2004-09-29 | 李政育 | Traditional Chinese medicine for treating paraplegia |
Non-Patent Citations (1)
Title |
---|
改良半夏泻心汤治疗慢性萎缩性胃炎实验研究. 金东明,吴巍,孙树权等.长春中医学院学报,第17卷第3期. 2001 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9193756B2 (en) | 2008-02-19 | 2015-11-24 | National University Corporation Asahikawa Medical College | Adrenomedullin production enhancer |
Also Published As
Publication number | Publication date |
---|---|
CN1745844A (en) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104491415A (en) | Medicine for treating chronic obstructive pulmonary disease during stable period and preparation method of medicine | |
WO2024099339A1 (en) | Traditional chinese medicine composition and use thereof | |
CN101745044A (en) | Chinese material medica preparation for treating nasosinusitis | |
CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
CN118021898B (en) | Traditional Chinese medicine composition for treating phlegm-stasis collateral obstruction type chronic atrophic gastritis with precancerous lesions | |
CN102988851B (en) | Chinese medicine composition for treating hemoptysis and preparation method of Chinese medicine composition | |
CN100361705C (en) | A traditional Chinese medicine composition for treating chronic atrophic gastritis | |
CN115040577B (en) | Traditional Chinese medicine composition for treating atrophic gastritis with intestinal metaplasia and atypical hyperplasia and preparation method thereof | |
CN105497811A (en) | Traditional Chinese medicine composition for treating liver cirrhosis and preparation technology thereof | |
CN102698189B (en) | Chinese medicinal composition and preparation with function of treating helicobacter pylori in stomach and preparation method thereof | |
CN106913626B (en) | A kind of pharmaceutical composition for treating enterogastritis and preparation method thereof, preparation and application | |
CN101327293B (en) | Capsule for treating peptic ulcer and preparation method thereof | |
CN105267818B (en) | A kind of Chinese medicine composition and preparation method thereof for treating epigastric pain | |
CN100409870C (en) | Chinese traditional medicinal composition for treating psoriasis | |
CN114832079A (en) | Traditional Chinese medicine composition for treating functional abdominal distension and preparation method thereof | |
CN113908250A (en) | Traditional Chinese medicine composition for treating chronic gastritis and preparation method and application thereof | |
CN1144595C (en) | Anticancer capsule | |
CN104491816A (en) | Application of a kind of traditional Chinese medicine composition in the preparation of medicine for treating chronic gastroenteritis | |
CN117045732B (en) | Traditional Chinese medicine composition for treating lipoma and preparation method and application thereof | |
CN118078942B (en) | Composition for treating obstructive sleep apnea-hypopnea syndrome, granule preparation and preparation method thereof | |
CN114732882B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN115845009B (en) | Umbilical moxibustion medicinal powder for treating spleen deficiency and diarrhea and its application | |
CN103182037A (en) | Traditional Chinese medicine for treating rhinitis | |
CN108619371A (en) | A kind of Traditional Chinese medicine compound composition and preparation method thereof with treatment kidney trouble | |
CN102552866A (en) | Medicament for treating refractory and recurrent oral ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Changchun Puhua Pharmaceutical Co., Ltd. Assignor: Changchun Institue of Applied Chemistry, Chinese Academy of Sciences Contract record no.: 2010220000048 Denomination of invention: Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof Granted publication date: 20080116 License type: Exclusive License Open date: 20060315 Record date: 20101116 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080116 Termination date: 20190930 |